Your browser doesn't support javascript.
loading
Real-world use of systemic therapies in men with metastatic castration resistant prostate cancer (mCRPC) in Canada.
Shayegan, Bobby; Wallis, Christopher J D; Malone, Shawn; Cagiannos, Ilias; Hamilton, Robert J; Ferrario, Cristano; Gotto, Geoffrey T; Basappa, Naveen S; Morgan, Scott C; Fernandes, Ricardo; Morash, Christopher; Niazi, Tamim; Noonan, Krista L; Rendon, Ricardo; Osborne, Brendan; Park-Wyllie, Laura; Chan, Katherine F Y; Hotte, Sebastien J; Saad, Fred.
Afiliación
  • Shayegan B; St. Joseph's Healthcare, McMaster University, Hamilton, ON, Canada.
  • Wallis CJD; Department of Urology, Vanderbilt University Medical Center, Nashville, TN; Division of Urology, Department of Surgery, Mount Sinai Hospital, Toronto, ON, Canada. Electronic address: wallis.cjd@gmail.com.
  • Malone S; The Ottawa Hospital, University of Ottawa, Ottawa, ON, Canada.
  • Cagiannos I; The Ottawa Hospital, University of Ottawa, Ottawa, ON, Canada.
  • Hamilton RJ; Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada.
  • Ferrario C; Jewish General Hospital, McGill University, Montreal, QC, Canada.
  • Gotto GT; Southern Alberta Institute of Urology, University of Calgary, Calgary, AB, Canada.
  • Basappa NS; Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada.
  • Morgan SC; The Ottawa Hospital, University of Ottawa, Ottawa, ON, Canada.
  • Fernandes R; London Health Sciences Centre, Western University, London, ON, Canada.
  • Morash C; The Ottawa Hospital, University of Ottawa, Ottawa, ON, Canada.
  • Niazi T; Jewish General Hospital, McGill University, Montreal, QC, Canada.
  • Noonan KL; BC Cancer Agency, University of British Columbia, Surrey, BC, Canada.
  • Rendon R; Queen Elizabeth II Health Sciences Centre, Dalhousie University, Halifax, NS, Canada.
  • Osborne B; Medical Affairs, Janssen Inc, Toronto, ON, Canada.
  • Park-Wyllie L; Medical Affairs, Janssen Inc, Toronto, ON, Canada.
  • Chan KFY; Medical Affairs, Janssen Inc, Toronto, ON, Canada.
  • Hotte SJ; Juravinski Cancer Centre, McMaster University, Hamilton, ON, Canada.
  • Saad F; Centre Hospitalier de l'Université de Montréal, University of Montreal, Montreal, QC, Canada.
Urol Oncol ; 40(5): 192.e1-192.e9, 2022 05.
Article en En | MEDLINE | ID: mdl-35216890
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata Resistentes a la Castración Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Humans / Male País/Región como asunto: America do norte Idioma: En Revista: Urol Oncol Asunto de la revista: NEOPLASIAS / UROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata Resistentes a la Castración Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Humans / Male País/Región como asunto: America do norte Idioma: En Revista: Urol Oncol Asunto de la revista: NEOPLASIAS / UROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Canadá